Online Clinical Case Study (June 2004)
The
content of the Office Cardiology Series is provided by:
Dr. Li Siu Lung, Steven
M.B.,B.S.(H.K.),
M.R.C.P.(U.K.), F.H.K.A.M., F.H.K.C.P., F.R.C.P.(Glasg.), F.R.C.P.(Edin.), Specialist
in Cardiology
Dr.
Wong Shou Pang, Alexander
F.R.C.P.,
F.H.K.A.M.(Med.), F.H.K.C.P., Specialist in Cardiology
臨床心臟科個案研究之內容誠蒙李少隆醫生及王壽鵬醫生提供。
Controversies in the Management of Atrial Fibrillation
Please indicate true or false to the following statements with supporting explanation.
Answers
| 1. |
Maintenance of sinus rhythm is always more important than rate control. |
|
False. Traditionally, maintenance of sinus rhythm is regarded as superior to rate control in terms of long term outcome. However, studies in recent years have shown that anticoagulation is the most important therapy in preventing stroke in patients with AF. In patients with risks factors for stroke (age>75years, history of stroke/ TIA, hypertension, hypertension and heart failure), anticoagulation is needed for both rhythm and rate control strategies. Nonetheless, treatment plan should be individualized. Cardioversion is probably still indicated, at least once, in patients with newly onset AF. This is particularly true in situations where AV synchrony is important, e.g. in patients with congestive heart failure. |
|
|
|
|
| 2. |
3 weeks of anticoagulation is the norm prior to electrical cardioversion. |
|
False. The ACUTE trial had clearly verified the equivalence of the TEE (transesophageal echocardiogram) approach and conventional anticoagulation approach before cardioversion. With the TEE approach, patients without evidence of thrombus on TEE received cardioversion immediately under cover with IV heparin without the conventional 3 weeks of anticoagulation therapy. At eight weeks of follow up, there was no difference in the embolic rates, deaths, maintenance of sinus rhythm and functional status. However, it should be noted that all patients in both groups received anticoagulation for eight weeks after cardioversion because atrial stunning may persist for a few weeks after cardioversion. |
|
|
|
|
| 3. | Amiodarone is the best drug for maintenance of sinus rhythm. |
|
True. In the CTAF (Canadian Trial of Atrial Fibrillation) and AFFIRM trials (The Atrial Fibrillation Followup Investigation of Rhythm Management), patients on amiodarone are more likely (69% and 62%) to stay in sinus rhythm when compared with other regimes (such as class I agents). However, the long-term side effects of amiodarone are a major consideration for its routine use. On the other hand, the efficacy rate of Sotalol and other class I drugs are in the range of 23% to 39% only. |
|
|
|
|
| 4. | Digoxin is the best drug for rate control. |
|
False. Digoxin is effective in controlling the ventricular response of AF at rest but not during exercise. A combination of beta-blocker (such as atenolol 50mg) with digoxin is the most effective approach with the combined use of digoxin and diltiazem the next choice. If rate control failed with appropriate medications, the next therapy that could be considered is AV nodal radiofrequency ablation and pacemaker placement. It has been shown that this technique preserved exercise tolerance and ejection fraction as effective as medical therapy and was marginally more effective in relieving symptoms and improving quality of life. |
|
|
|
|
|
References: |
|
| Back to top |
A 40 year old gentleman presented with asymptomatic linear reddish depressions on his right axilla extending to nearby back, shoulder and arm for six months. There was no similar lesion elsewhere. He admitted preceding application of over-the-counter topical drug for 'fungal' infection on the right axilla before occurrence of the skin lesion. His past health was good. There was no recent weight gain.
| The
content of the Dermatology Series is provided by: Dr. Tang Yuk Ming, William and Dr. Chan Loi Yuen Specialist in Dermatology & Venereology 皮膚科病例研究之內容誠蒙鄧旭明醫生及陳來源醫生提供。 |
Answers